MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Breast Cancer Research and Treatment
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

814 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
814 works in the cohort · of 4,299,418page 3 of 17

Labels cover 3 of 814 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 814 of 814 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundno abstractunlabeled
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
Lynne I. Wagner, Fengmin Zhao, Paul E. Goss, J. W. Chapman, Lois E. Shepherd, Timothy J. Whelan +9 more
2018· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
95
citations
affno abstractunlabeled
Breast cancer in pregnancy: a literature review
Andrea Molckovsky, Yolanda Madarnas
2007· review· en· Breast Cancer Research and Treatment· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
95
citations
affno abstractunlabeled
Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
Magda Conceição Barbosa Gomes, Maurício Magalhães Costa, Radovan Borojević, Álvaro N.A. Monteiro, Roberto José da Silva Vieira, Sérgio Koifman +5 more
2006· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
88
citations
affunlabeled
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
Nicholas C. Turner, Rebecca Dent, Joyce O’Shaughnessy, Sung‐Bae Kim, Steven J. Isakoff, Carlos H. Barrios +10 more
2021· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
88
citations
affno abstractunlabeled
Molecular insights on basal-like breast cancer
Mev Dominguez–Valentin, Sabrina Daniela da Silva, Maud Privat, Moulay A. Alaoui‐Jamali, Yves‐Jean Bignon
2012· review· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
85
citations
afffundno abstractunlabeled
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
Kelly Metcalfe, Henry T. Lynch, Parviz Ghadirian, Nadine Tung, Charmaine Kim‐Sing, Olufunmilayo I. Olopade +7 more
2011· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
78
citations
affno abstractunlabeled
A Phase 2 study of perifosine in advanced or metastatic breast cancer
Natasha B. Leighl, Susan Dent, Mark Clemons, Theodore A. Vandenberg, Richard Tozer, David Warr +5 more
2007· article· en· Breast Cancer Research and Treatment· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
77
citations
← previousnext →

How this was built: Screen · Findings · About